Viktoriia Sokolova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Viktoriia Sokolova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Bernard Haines
Department of Materials Science & Engineering and A.J. Drexel Nanomaterials Institute, Drexel University, Philadelphia, Pennsylvania 19104, United States
1 shared publication- Fayan Meng
Pharmaceutical College, Guangxi Medical University , No. 22 Shuangyong Road, Nanning 530021, Guangxi
1 shared publication - Hai-Feng Ji
Drexel University
1 shared publication Lon Stone
Consultants Rx, Dana Point, California 92629, United States
1 shared publication- Lyuba Mikhalovska
School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK
1 shared publication - Mykola Seredych
Department of Chemistry, The City College of New York, 160 Convent Avenue, New York, New York 10031, United States
1 shared publication
Latest Publications
- 18 October 2023
- Published by Drexel University Libraries
Development of a small molecule drug for inhibition of TIPE2 protein function
This work focuses on designing a small molecule drug to inhibit the function of TNF-[alpha]-induced protein 8-like 2 (TIPE2). The protein is known to play an important role in leukocyte polarization and migration, both of which are exploited by tumor cells in cases of cancer to sustain its proliferation and growth. Several hit compounds were pre-selected based on their TIPE2-binding affinity, and their virtual modification is discussed in this work. Avogadro and PyRx were used to determine the conformation of the ligand and the protein-ligand binding affinity, respectively. Binding interactions between different functional groups and TIPE2 are discussed in detail and provide additional insight to the structure of the TIPE2 binding pocket. The protein has a highly hydrophobic cavity which interacts best with aromatic groups. At the same time, aromatic substituents have been found to decrease solubility of compounds far below the desired limit. Introducing N-containing heterocycles is an efficient modification strategy that has been found to give the most optimal balance between desired properties. Two best compounds were selected due to their highest binding score of -11.1 kcal/mol and their solubility values of greater than -3.0 logS. Synthetic pathway was developed for one of the compounds, with alternative methods available to either improve the efficiency or decrease the cost of the process.
- 18 October 2023
- Published by Drexel University Libraries
Development of a small molecule drug for inhibition of TIPE2 protein function
This work focuses on designing a small molecule drug to inhibit the function of TNF-[alpha]-induced protein 8-like 2 (TIPE2). The protein is known to play an important role in leukocyte polarization and migration, both of which are exploited by tumor cells in cases of cancer to sustain its proliferation and growth. Several hit compounds were pre-selected based on their TIPE2-binding affinity, and their virtual modification is discussed in this work. Avogadro and PyRx were used to determine the conformation of the ligand and the protein-ligand binding affinity, respectively. Binding interactions between different functional groups and TIPE2 are discussed in detail and provide additional insight to the structure of the TIPE2 binding pocket. The protein has a highly hydrophobic cavity which interacts best with aromatic groups. At the same time, aromatic substituents have been found to decrease solubility of compounds far below the desired limit. Introducing N-containing heterocycles is an efficient modification strategy that has been found to give the most optimal balance between desired properties. Two best compounds were selected due to their highest binding score of -11.1 kcal/mol and their solubility values of greater than -3.0 logS. Synthetic pathway was developed for one of the compounds, with alternative methods available to either improve the efficiency or decrease the cost of the process.
- 18 July 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (2) , 436-443
Graphene-Based Materials for the Fast Removal of Cytokines from Blood Plasma
There is a range of medical conditions, which include acute organ failure, bacterial and viral infection and sepsis, that result in over-activation of the inflammatory response of the organism and release of pro-inflammatory cytokines into the bloodstream. A fast removal of these cytokines from blood circulation could offer a potentially efficient treatment of such conditions. This study aims at the development and assessment of novel biocompatible graphene-based adsorbents for blood purification from pro-inflammatory cytokines. These graphene-based materials were chosen on the basis of their surface accessibility for small molecules further facilitated by the interlayer porosity, which is comparable to the size of the cytokine molecules to be adsorbed. Our preliminary results show that graphene nanoplatelets (GnP) exhibit high adsorption capacity, but they cannot be used in direct contact with blood due to the risk of small carbon particles release into the bloodstream. Granulation of GnP using poly(tetrafluoroethylene) (PTFE) as a binder eliminated an undesirable nanoparticle release without affecting the GnP surface accessibility for the cytokines molecules. The efficiency of pro-inflammatory cytokine removal was shown using a specially designed flow-through system. So far, GnP proved to be among the fastest acting and most efficient sorbents for cytokine removal identified to date, outperforming porous activated carbons and porous polymers.
- 18 July 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (2) , 436-443
Graphene-Based Materials for the Fast Removal of Cytokines from Blood Plasma
There is a range of medical conditions, which include acute organ failure, bacterial and viral infection and sepsis, that result in over-activation of the inflammatory response of the organism and release of pro-inflammatory cytokines into the bloodstream. A fast removal of these cytokines from blood circulation could offer a potentially efficient treatment of such conditions. This study aims at the development and assessment of novel biocompatible graphene-based adsorbents for blood purification from pro-inflammatory cytokines. These graphene-based materials were chosen on the basis of their surface accessibility for small molecules further facilitated by the interlayer porosity, which is comparable to the size of the cytokine molecules to be adsorbed. Our preliminary results show that graphene nanoplatelets (GnP) exhibit high adsorption capacity, but they cannot be used in direct contact with blood due to the risk of small carbon particles release into the bloodstream. Granulation of GnP using poly(tetrafluoroethylene) (PTFE) as a binder eliminated an undesirable nanoparticle release without affecting the GnP surface accessibility for the cytokines molecules. The efficiency of pro-inflammatory cytokine removal was shown using a specially designed flow-through system. So far, GnP proved to be among the fastest acting and most efficient sorbents for cytokine removal identified to date, outperforming porous activated carbons and porous polymers.